Showing results (531-540 of 675) with videos related to
Sort By:
Pageof 68
Neurology|August 25, 2022
Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent EpilepsyCurtis R Coughlin, Laura A Tseng, Levinus A Bok, et al.Epilepsia|January 31, 2013
Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significanceFederico Zara, Nicola Specchio, Pasquale Striano, et al.Epilepsia Open|May 12, 2018
EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation processPeter S Bergin, Ettore Beghi, Lynette G Sadleir, et al.Annals of Clinical and Translational Neurology|December 2, 2020
Trait impulsivity in Juvenile Myoclonic EpilepsyAmy Shakeshaft, Naim Panjwani, Robert McDowall, et al.Frontiers in Neurology|November 23, 2020
Cyclic Vomiting Syndrome in ChildrenUmberto Raucci, Osvaldo Borrelli, Giovanni Di Nardo, et al.Scientific Reports|February 22, 2022
Sex-specific disease modifiers in juvenile myoclonic epilepsyAmy Shakeshaft, Naim Panjwani, Amber Collingwood, et al.Neurology|March 16, 2022
Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With AbsencesEmanuele Cerulli Irelli, Enrico Cocchi, Georgia Ramantani, et al.Ebiomedicine|July 30, 2025
SUDEP risk is influenced by longevity genomics: a polygenic risk score studyHelena Martins, James D Mills, Susanna Pagni, et al.Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.Seizure|January 29, 2016
Effectiveness of antiepileptic therapy in patients with PCDH19 mutationsJan Lotte, Thomas Bast, Peter Borusiak, et al.Pageof 68